5-Aza-2'-deoxycytidine (decitabine) and 5-azacytidine in the treatment of acute myeloid leukemias and myelodysplastic syndromes : past, present and future trendsPINTO, A; ZAGONEL, V.Leukemia. 1993, Vol 7, pp 51-60, issn 0887-6924, SUP1Article

CIS-PLATINUM AND ETOPOSIDE COMBINATION CHEMOTHERAPY OF ADVANCED NON-OAT CELL BRONCHOGENIC CARCINOMAVERONESI A; ZAGONEL V; SANTAROSSA M et al.1983; CANCER CHEMOTHERAPY AND PHARMACOLOGY; ISSN 0344-5704; DEU; DA. 1983; VOL. 11; NO 1; PP. 35-37; BIBL. 14 REF.Article

VINDESINE OVERDOSEFIORENTINO MV; SALVAGNO L; CHIARION SELENI V et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 5; PP. 1247-1248; BIBL. 2 REF.Article

Geriatric Oncology: Focus on MyelodepressionREPETTO, L; TRALONGO, P; ZAGONEL, V et al.Critical reviews in oncology/hematology. 2003, Vol 48, issn 1040-8428, 75 p., SUPConference Proceedings

Acute myeloid leukemia in the elderly : biology and therapeutic strategiesPINTO, A; ZAGONEL, V; FERRARA, F et al.Critical reviews in oncology/hematology. 2001, Vol 39, Num 3, pp 275-287, issn 1040-8428Article

Cost analyses of granulocyte colony stimulating factor: a focus on older patients with cancerBENNETT, Charles L.Critical reviews in oncology/hematology. 2003, Vol 48, pp S71-S74, issn 1040-8428, SUPConference Paper

B-zone small lymphocytic lymphoma : a morphologic, immunophenotypic, and clinical study with comparison to well-differentiated lymphocytic disordersCARBONE, A; PINTO, A; GLOGHINI, A et al.Human pathology. 1992, Vol 23, Num 4, pp 438-448, issn 0046-8177Article

Complications of cytotoxic chemotherapy in older patients: focus on myelotoxicity in lymphomasZINZANI, Pier Luigi.Critical reviews in oncology/hematology. 2003, Vol 48, pp S27-S31, issn 1040-8428, SUPConference Paper

Supportive care of the older cancer patientBALDUCCI, Lodovico; CARRECA, Ignazio.Critical reviews in oncology/hematology. 2003, Vol 48, pp S65-S70, issn 1040-8428, SUPConference Paper

Phase II study of teniposide (VM26) in cutaneous T-cell lymphomasSORIO, R; TIRELLI, U; ZAGONEL, V et al.American journal of clinical oncology. 1990, Vol 13, Num 1, pp 14-16, issn 0277-3732, 3 p.Article

Treatment of non-hodgkin's lymphoma in the elderly : An updateTIRELLI, U; ZAGONEL, V; ERRANTE, D et al.Hematological oncology. 1998, Vol 16, Num 1, pp 1-13, issn 0278-0232Article

Non-Hodgkin's lymphomas in the elderly: prospective studies with specifically devised chemotherapy regimens in 66 patientsTIRELLI, U; CARBONE, A; ZAGONEL, V et al.European journal of cancer & clinical oncology. 1987, Vol 23, Num 5, pp 535-540, issn 0277-5379Article

A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma : the END-I study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) groupPIGNATA, S; SCAMBIA, G; RIVA, N et al.British journal of cancer. 2007, Vol 96, Num 11, pp 1639-1643, issn 0007-0920, 5 p.Article

Optimising management of neutropenia and anaemia in cancer chemotherapy-advances in cytokine therapySIENA, Salvatore; SECONDINO, Simona; GIANNETTA, Laura et al.Critical reviews in oncology/hematology. 2003, Vol 48, pp S59-S47, issn 1040-8428, SUPConference Paper

ALK⁺ lymphoma : Clinico-pathological findings and outcomeFALINI, B; PILERI, S; LAZZARINO, M et al.Blood. 1999, Vol 93, Num 8, pp 2697-2706, issn 0006-4971Article

Differential expression of the RET gene in human acute myeloid leukemiaGATTEI, V; DEGAN, M; ALDINUCCI, D et al.Annals of hematology (Print). 1998, Vol 77, Num 5, pp 207-210, issn 0939-5555Article

Hodgkin's disease : A disorder of dysregulated cellular cross-talkPINTO, A; GATTEI, V; POLETTO, D et al.Biotherapy (Dordrecht). 1998, Vol 10, Num 4, pp 309-320, issn 0921-299XArticle

Characterization of overt B-cell lymphomas in patients with hepatitis C virus infectionDE VITA, S; SACCO, C; ZAGONEL, V et al.Blood. 1997, Vol 90, Num 2, pp 776-782, issn 0006-4971Article

Expression of the RET receptor tyrosine kinase and GDNFR-α in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironmentGATTEI, V; CELETTI, A; ALDINUCCI, D et al.Blood. 1997, Vol 89, Num 8, pp 2925-2937, issn 0006-4971Article

Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapyZAGONEL, V; BABARE, R; MEROLA, M. C et al.Annals of oncology. 1994, Vol 5, pp 127-132, issn 0923-7534, SUP2Conference Paper

In vitro and in vivo effects of 5-aza-2'-deoxycytidine (decitabine) on clonogenic cells from acute myeloid leukemia patientsGATTEI, V; ALDINUCCI, D; PETTI, M. C et al.Leukemia. 1993, Vol 7, pp 42-48, issn 0887-6924, SUP1Article

Phase II study of teniposide (VM-26) in multiple myelomaTIRELLI, U; ZAGONEL, V; VERONESI, A et al.American journal of clinical oncology. 1985, Vol 8, Num 4, pp 329-331, issn 0277-3732Article

Opinions concerning euthanasia, life-sustaining treatment and acceleration of death : results of an Italian Association of Medical Oncology (AIOM) surveyCATANIA, C; ZAGONEL, V; FOSSER, V et al.Annals of oncology. 2008, Vol 19, Num 11, pp 1947-1954, issn 0923-7534, 8 p.Article

Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)DEL MASTRO, L; PERRONE, F; CATZEDDU, T et al.Annals of oncology. 2005, Vol 16, Num 2, pp 253-258, issn 0923-7534, 6 p.Article

Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasiaCAPELLO, D; VITOLO, U; LANZA, C et al.Blood. 2000, Vol 95, Num 2, pp 651-659, issn 0006-4971Article